Wenfang Xia Selected Research

Insulin Resistance

1/2018	Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice.
1/2016	Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
6/2014	[The effect of NALP3 inflammasome pathway in visceral adipose tissue on the development of insulin resistance in catch-up growth after food restriction in rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenfang Xia Research Topics

Disease

5	Sepsis (Septicemia) 01/2023 - 06/2019
3	Insulin Resistance 01/2018 - 06/2014
3	Heart Failure 05/2014 - 09/2010
2	Infections 01/2023 - 01/2021
2	COVID-19 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2018 - 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2024
1	Hypoalbuminemia 01/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2024
1	Glucosephosphate Dehydrogenase Deficiency 01/2024
1	Albuminuria 05/2023
1	Type 2 Diabetes Mellitus (MODY) 05/2023
1	Chronic Renal Insufficiency 05/2023
1	Tuberculosis (Tuberculoses) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Hyperglycemia 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Carcinogenesis 01/2020
1	Acute Lung Injury 07/2019
1	Hypercapnia 01/2019
1	Pulmonary Edema 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Obesity 01/2018
1	Atrial Fibrillation 06/2017
1	Ventricular Fibrillation 05/2014
1	Cardiac Arrhythmias (Arrythmia) 05/2014
1	Ventricular Tachycardia 05/2014
1	Ischemia 05/2014
1	Fibrosis (Cirrhosis) 10/2010
1	Atrial Remodeling 09/2010

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2021
2	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2023 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 01/2020
2	ERRalpha Estrogen-Related ReceptorIBA 01/2023 - 01/2020
2	XCT790IBA 01/2020 - 06/2019
2	salicylhydroxamic acid (SHAM)IBA 06/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2014
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2010 - 09/2010
1	C-Reactive ProteinIBA 01/2024
1	ProcalcitoninIBA 01/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2023
1	AlbuminsIBA 05/2023
1	CreatineIBA 05/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2023
1	SodiumIBA 05/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2023
1	galactomannanIBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Testosterone (Sustanon)FDA Link 01/2023
1	GlucansIBA 01/2023
1	HDL CholesterolIBA 01/2021
1	Long Noncoding RNAIBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Multidrug Resistance-Associated ProteinsIBA 07/2019
1	Estrogens (Estrogen)FDA Link 06/2019
1	CytokinesIBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2018
1	LipidsIBA 01/2018
1	Atropine FDA LinkGeneric 06/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2017
1	Small Interfering RNA (siRNA)IBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Leucine (L-Leucine)FDA Link 06/2014
1	InflammasomesIBA 06/2014
1	Peptides (Polypeptides)IBA 05/2014
1	rotigaptideIBA 05/2014
1	Anti-Arrhythmia AgentsIBA 05/2014
1	acetovanillone (apocynin)IBA 10/2010
1	Connexin 43 (Connexin43)IBA 09/2010

Therapy/Procedure

3	Ligation 01/2023 - 06/2019
3	Punctures 01/2023 - 06/2019
1	Kidney Transplantation 01/2024
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Intraperitoneal Injections 06/2019
1	Vagotomy 01/2019